Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 103 articles:
HTML format



Single Articles


    March 2021
  1. MIMAE T, Saji H, Okada M
    ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?
    Ann Surg Oncol. 2021 Mar 23. pii: 10.1245/s10434-021-09860.
    PubMed    


  2. ZENG Q, Li J, Tan F, Sun N, et al
    Development and Validation of a Nomogram Prognostic Model for Resected Limited-Stage Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2021 Mar 2. pii: 10.1245/s10434-020-09552.
    PubMed     Abstract available


    February 2021
  3. TSUDAKA S, Yamamoto H, Sato H, Toyooka S, et al
    ASO Author Reflections: Impact of the Postoperative Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small Cell Lung Cancer Treated with Induction Chemoradiotherapy Followed by Surgery.
    Ann Surg Oncol. 2021 Feb 25. pii: 10.1245/s10434-021-09699.
    PubMed    


  4. TSUDAKA S, Yamamoto H, Sato H, Katsui K, et al
    Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small-cell Lung Cancer Treated with Trimodality Therapy.
    Ann Surg Oncol. 2021 Feb 25. pii: 10.1245/s10434-021-09690.
    PubMed     Abstract available


    January 2021
  5. LI S, Wu N
    ASO Author Reflections: Proposed Nodal Categories for Future Editions of the TNM Classification of Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Jan 9. pii: 10.1245/s10434-020-09516.
    PubMed    


  6. LI S, Yan S, Lu F, Lv C, et al
    Validation of the 8th Edition Nodal Staging and Proposal of New Nodal Categories for Future Editions of the TNM Classification of Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Jan 2. pii: 10.1245/s10434-020-09461.
    PubMed     Abstract available


  7. SHIGEFUKU S, Shimada Y, Hagiwara M, Kakihana M, et al
    Prognostic Significance of Ground-Glass Opacity Components in 5-Year Survivors With Resected Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:148-156.
    PubMed     Abstract available


    December 2020
  8. LEINWAND JC, Kluger MD
    ASO Author Reflections: Improving Outcomes in Diffuse Malignant Peritoneal Mesothelioma: Challenges and Opportunities.
    Ann Surg Oncol. 2020;27.
    PubMed    


    November 2020
  9. ZUO Z, Zhang G, Song P, Yang J, et al
    Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort.
    Ann Surg Oncol. 2020 Nov 28. pii: 10.1245/s10434-020-09362.
    PubMed     Abstract available


  10. YAMAMOTO H, Yamamoto H, Soh J, Suzuki E, et al
    A Simple Prognostic Benefit Scoring System for Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score.
    Ann Surg Oncol. 2020 Nov 24. pii: 10.1245/s10434-020-09272.
    PubMed     Abstract available


  11. YAMAMOTO H, Yamamoto H, Toyooka S
    A New Scoring System for Predicting the Survival of Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score.
    Ann Surg Oncol. 2020 Nov 4. pii: 10.1245/s10434-020-09299.
    PubMed    


    October 2020
  12. EBY M, Seder CW
    Reply to "Letter to the editor of Annals of Surgical Oncology Concerning " The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer" by Sunil Kumar et al.
    Ann Surg Oncol. 2020 Oct 26. pii: 10.1245/s10434-020-09258.
    PubMed    


  13. KUMAR N, Bhoriwal S, Kumar S
    Letter to the Editor of Annals of Surgical Oncology Concerning "The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer".
    Ann Surg Oncol. 2020 Oct 22. pii: 10.1245/s10434-020-09249.
    PubMed    


  14. MATSUBARA T, Takamori S, Haratake N, Fujishita T, et al
    Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2020 Oct 21. pii: 10.1245/s10434-020-09230.
    PubMed     Abstract available


  15. KANZAKI R
    ASO Author Reflections: Long-Term Outcomes of Pulmonary Metastasectomy for Uterine Malignancies: A Multi-institutional Study in the Current Era.
    Ann Surg Oncol. 2020;27:3829-3830.
    PubMed    


  16. TANG WF, Zhong WZ
    ASO Author Reflections: Lung Adenocarcinoma with Accidental Invisible Pleural Dissemination Lesions: Wait-and-See Strategy for Tumors with Indolent Biologic Characteristics.
    Ann Surg Oncol. 2020;27:3819-3820.
    PubMed    


  17. JUNG W, Cho S, Yum S, Chung JH, et al
    Stepwise Disease Progression Model of Subsolid Lung Adenocarcinoma with Cystic Airspaces.
    Ann Surg Oncol. 2020;27:4394-4403.
    PubMed     Abstract available


  18. TSAI PC, Yeh YC, Hsu PK, Chen CK, et al
    CT-Guided Core Biopsy for Peripheral Sub-solid Pulmonary Nodules to Predict Predominant Histological and Aggressive Subtypes of Lung Adenocarcinoma.
    Ann Surg Oncol. 2020;27:4405-4412.
    PubMed     Abstract available


    September 2020
  19. CHEN D, Ding Q, Wang W, Chen C, et al
    ASO Author Reflections: Old Song, New Sung-Extracapsular Extension in Lung Cancer in the Era of Eighth-Edition N Classification.
    Ann Surg Oncol. 2020 Sep 22. pii: 10.1245/s10434-020-09173.
    PubMed    


  20. WANKHEDE D
    Evaluation of Eighth AJCC TNM Sage for Lung Cancer NSCLC: A Meta-analysis.
    Ann Surg Oncol. 2020 Sep 20. pii: 10.1245/s10434-020-09151.
    PubMed     Abstract available


  21. CHEN Y, Zhang J, Chen L, Dai J, et al
    Lymph Node Examination for Stage I Second Primary Lung Cancer Patients Who Received Second Surgical Treatment.
    Ann Surg Oncol. 2020 Sep 5. pii: 10.1245/s10434-020-08975.
    PubMed     Abstract available


    August 2020
  22. ZHU Y, Liu L
    ASO Author Reflections: A Novel Concept to Decreasing the Technical Difficulty of Complex Pulmonary Segmentectomy.
    Ann Surg Oncol. 2020;27:3094-3095.
    PubMed    


    July 2020
  23. MASCALCHI M
    Lung Cancer Associated with Cystic Airspaces in the Screening Perspective.
    Ann Surg Oncol. 2020 Jul 22. pii: 10.1245/s10434-020-08929.
    PubMed    


  24. LIU C, Wei S, Liu L
    ASO Author Reflections: Individualized Mediastinal Lymph Node Dissection for Lung Cancer: Do Not Neglect Station 3A Lymph Node.
    Ann Surg Oncol. 2020 Jul 20. pii: 10.1245/s10434-020-08876.
    PubMed    


  25. TAKAMORI S, Shimokawa M, Matsubara T, Haratake N, et al
    Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2020 Jul 16. pii: 10.1245/s10434-020-08851.
    PubMed     Abstract available


  26. YANG Y, Mei J, Lin F, Pu Q, et al
    Comparison of the Short- and Long-term Outcomes of Video-assisted Thoracoscopic Surgery versus Open Thoracotomy Bronchial Sleeve Lobectomy for Central Lung Cancer: A Retrospective Propensity Score Matched Cohort Study.
    Ann Surg Oncol. 2020 Jul 8. pii: 10.1245/s10434-020-08805.
    PubMed     Abstract available


  27. TAKAMORI S, Okamoto T, Mori M
    ASO Author Reflections: Which of Smoking Duration or Smoking Intensity Contributes to Poor Prognosis After Resection of Non-small Cell Lung Cancer?
    Ann Surg Oncol. 2020 Jul 8. pii: 10.1245/s10434-020-08852.
    PubMed    


  28. LIU C, Wei S, Guo C, Mei J, et al
    Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.
    Ann Surg Oncol. 2020 Jul 7. pii: 10.1245/s10434-020-08786.
    PubMed     Abstract available


    June 2020
  29. ZHANG Y, Li G, Li Y, Liu Q, et al
    Imaging Features Suggestive of Multiple Primary Lung Adenocarcinomas.
    Ann Surg Oncol. 2020;27:2061-2070.
    PubMed     Abstract available


  30. WANG C, Yang J, Lu M
    Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy.
    Ann Surg Oncol. 2020;27:2051-2060.
    PubMed     Abstract available


  31. KINOSHITA F, Takada K, Yamada Y, Oku Y, et al
    Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.
    Ann Surg Oncol. 2020;27:2102-2109.
    PubMed     Abstract available


    May 2020
  32. EBY ME, Seder CW
    The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2020 May 9. pii: 10.1245/s10434-020-08553.
    PubMed    


  33. BEKHOR E, Carr J, Hofstedt M, Sullivan B, et al
    The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database Analysis.
    Ann Surg Oncol. 2020;27:1448-1455.
    PubMed     Abstract available


    April 2020
  34. ZHANG X, Moriwaki T, Kawabata T, Goto S, et al
    Nicaraven Attenuates Postoperative Systemic Inflammatory Responses-Induced Tumor Metastasis.
    Ann Surg Oncol. 2020;27:1068-1074.
    PubMed     Abstract available


    March 2020
  35. CHIANG XH, Hsu HH, Hsieh MS, Chang CH, et al
    Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma.
    Ann Surg Oncol. 2020;27:703-715.
    PubMed     Abstract available


  36. CHIANG XH, Lin MW, Chen JS
    Indication for Sublobar Resection in cT1N0 Lung Adenocarcinoma is Contentious.
    Ann Surg Oncol. 2020;27:956-957.
    PubMed    


  37. KISHI N, Ito M, Miyata Y, Kanai A, et al
    Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component.
    Ann Surg Oncol. 2020;27:945-955.
    PubMed     Abstract available


  38. LIN MW, Chen JS
    ASO Author Reflections: Sublobar Resection En Route to Becoming the Standard of Care for cT1N0 Lung Adenocarcinoma.
    Ann Surg Oncol. 2020;27:716-717.
    PubMed    


    February 2020
  39. BOEDING JRE, Schreinemakers JMJ
    ASO Author Reflections: Patterns of Metastases in Patients with Obstructing Colorectal Cancer.
    Ann Surg Oncol. 2020 Feb 11. pii: 10.1245/s10434-020-08250.
    PubMed    


    January 2020
  40. SHINOHARA S, Otsuki R, Kobayashi K, Sugaya M, et al
    Impact of Sarcopenia on Surgical Outcomes in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2020 Jan 22. pii: 10.1245/s10434-020-08224.
    PubMed     Abstract available


  41. LETICA-KRIEGEL AS, Leinwand JC, Sonett JR, Gorenstein LA, et al
    50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience.
    Ann Surg Oncol. 2020;27:205-213.
    PubMed     Abstract available


    December 2019
  42. DENG HY
    Sublobar Resection for Clinical IA Non-Small Cell Lung Cancer: One Size Fits All?
    Ann Surg Oncol. 2019 Dec 19. pii: 10.1245/s10434-019-08146.
    PubMed    


  43. BROUWER NPM, van der Kruijssen DEW, Hugen N, de Hingh IHJT, et al
    The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival.
    Ann Surg Oncol. 2019 Dec 2. pii: 10.1245/s10434-019-08100.
    PubMed     Abstract available


  44. AVERY KNL, Blazeby JM, Chalmers KA, Batchelor TJP, et al
    Impact on Health-Related Quality of Life of Video-Assisted Thoracoscopic Surgery for Lung Cancer.
    Ann Surg Oncol. 2019 Dec 1. pii: 10.1245/s10434-019-08090.
    PubMed     Abstract available


    November 2019
  45. KARUSH JM
    Are Lobe-Specific Mediastinal Lymph Node Dissections Reasonable for Peripheral Stage Ia Non-small Cell Lung Cancer?
    Ann Surg Oncol. 2019 Nov 6. pii: 10.1245/s10434-019-08069.
    PubMed    


  46. NAKAZAWA N, Yokobori T, Turtoi A, Shirabe K, et al
    ASO Author Reflections: High Stromal TGFBI is a Useful Predictive Marker for Nivolumab in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2019 Nov 6. pii: 10.1245/s10434-019-08057.
    PubMed    


    October 2019
  47. SHINOHARA S, Kobayashi K, Nakagawa M
    ASO Author Reflections: The Possibility of a New Prognostic Biomarker of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2019 Oct 28. pii: 10.1245/s10434-019-08004.
    PubMed    


  48. DENG HY, Zhou Q
    ASO Author Reflections: Lobe-Specific Lymph Node Dissection for Early-Stage Non-small Cell Lung Cancer: A Long Way to Go in the Era of Minimally Invasive Thoracic Surgery.
    Ann Surg Oncol. 2019 Oct 16. pii: 10.1245/s10434-019-07946.
    PubMed    


  49. ZHANG X, Su XD
    ASO Author Reflections: Which Is a Better Way to Describe Tumor Size of Lung Cancer: Tumor Volume or Diameter?
    Ann Surg Oncol. 2019 Oct 16. pii: 10.1245/s10434-019-07938.
    PubMed    


  50. DENG HY, Zhou J, Wang RL, Jiang R, et al
    Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?
    Ann Surg Oncol. 2019 Oct 15. pii: 10.1245/s10434-019-07926.
    PubMed     Abstract available


  51. ASARE EA, Silva-Figueroa A, Hess KR, Busaidy N, et al
    Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center.
    Ann Surg Oncol. 2019;26:3593-3599.
    PubMed     Abstract available


    September 2019
  52. NAKAZAWA N, Yokobori T, Kaira K, Turtoi A, et al
    High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors.
    Ann Surg Oncol. 2019 Sep 30. pii: 10.1245/s10434-019-07878.
    PubMed     Abstract available


  53. ZENG Y, Mayne N, Yang CJ, Liang W, et al
    ASO Author Reflections: TNM 8th Edition: Stage I Non-small Cell Lung Cancer-Free from Recurrence and Adjuvant Therapy? How to Predict?
    Ann Surg Oncol. 2019 Sep 25. pii: 10.1245/s10434-019-07856.
    PubMed    


    August 2019
  54. LIU L, Zhang Z
    ASO Author Reflections: The Dissection of Station 4L Lymph Node for Left-Sided Non-Small Cell Lung Cancer Should Receive More Attention.
    Ann Surg Oncol. 2019 Aug 28. pii: 10.1245/s10434-019-07764.
    PubMed    


  55. SHINOHARA S, Otsuki R, Kobayashi K, Matsuo M, et al
    The Prognostic Impact of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2019 Aug 12. pii: 10.1245/s10434-019-07703.
    PubMed     Abstract available


  56. VERMA V, Wegner RE, Ludmir EB, Hasan S, et al
    Management of Malignant Pleural Mesothelioma in the Elderly Population.
    Ann Surg Oncol. 2019;26:2357-2366.
    PubMed     Abstract available


  57. QIAN J, Xu J, Wang S, Qian F, et al
    Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy.
    Ann Surg Oncol. 2019;26:2392-2400.
    PubMed     Abstract available


    July 2019
  58. LEE JH, Shin KM, Lee SY, Hong MJ, et al
    Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery.
    Ann Surg Oncol. 2019 Jul 16. pii: 10.1245/s10434-019-07614.
    PubMed     Abstract available


    June 2019
  59. IIJIMA M, Yokobori T, Mogi A, Shimizu K, et al
    Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma.
    Ann Surg Oncol. 2019;26:1744-1750.
    PubMed     Abstract available


  60. REN Y, Xie H, Dai C, She Y, et al
    Prognostic Impact of Tumor Spread Through Air Spaces in Sublobar Resection for 1A Lung Adenocarcinoma Patients.
    Ann Surg Oncol. 2019;26:1901-1908.
    PubMed     Abstract available


  61. LIU DH, Zhao ZR, Lin YB, Zhou WJ, et al
    Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma.
    Ann Surg Oncol. 2019;26:1934-1941.
    PubMed     Abstract available


  62. MATSUBARA T, Takada K, Azuma K, Takamori S, et al
    A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma.
    Ann Surg Oncol. 2019;26:1925-1933.
    PubMed     Abstract available


  63. TAKAMORI S, Takada K, Azuma K, Jogo T, et al
    Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients.
    Ann Surg Oncol. 2019;26:1916-1924.
    PubMed     Abstract available


    May 2019
  64. XIE HJ, Zhang X, Mo YX, Long H, et al
    Tumor Volume Is Better Than Diameter for Predicting the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2019 May 3. pii: 10.1245/s10434-019-07412.
    PubMed     Abstract available


  65. AKAMINE T, Tagawa T, Ijichi K, Toyokawa G, et al
    The Significance of CD44 Variant 9 in Resected Lung Adenocarcinoma: Correlation with Pathological Early-Stage and EGFR Mutation.
    Ann Surg Oncol. 2019;26:1544-1551.
    PubMed     Abstract available


  66. BEANE JD, Wilson GC, Sutton JM, Shuai Y, et al
    Pleuropulmonary Recurrence Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Appendiceal Pseudomyxoma Peritonei.
    Ann Surg Oncol. 2019;26:1429-1436.
    PubMed     Abstract available


    April 2019
  67. REINERSMAN JM
    Better Survival After 4L Lymph Node Dissection for Early-Stage, Left-Sided, Non-small Cell Lung Cancer: Are We Debating a False Duality?
    Ann Surg Oncol. 2019 Apr 23. pii: 10.1245/s10434-019-07382.
    PubMed    


  68. ZHAO K, Wei S, Mei J, Guo C, et al
    Survival Benefit of Left Lower Paratracheal (4L) Lymph Node Dissection for Patients with Left-Sided Non-small Cell Lung Cancer: Once Neglected But of Great Importance.
    Ann Surg Oncol. 2019 Apr 22. pii: 10.1245/s10434-019-07368.
    PubMed     Abstract available


    March 2019
  69. ZENG Y, Mayne N, Yang CJ, D'Amico TA, et al
    A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer.
    Ann Surg Oncol. 2019 Mar 21. pii: 10.1245/s10434-019-07318.
    PubMed     Abstract available


  70. PASTORINO U, Morelli D, Leuzzi G, Rolli L, et al
    Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy.
    Ann Surg Oncol. 2019;26:869-875.
    PubMed     Abstract available


    January 2019
  71. LIN MW, Huang YL, Yang CY, Kuo SW, et al
    The Differences in Clinicopathologic and Prognostic Characteristics Between Surgically Resected Peripheral and Central Lung Squamous Cell Carcinoma.
    Ann Surg Oncol. 2019;26:217-229.
    PubMed     Abstract available


  72. KAWAGUCHI Y, Hanaoka J, Ohshio Y, Okamoto K, et al
    Patient Survival after Surgical Management in Intrathoracic Pseudomyxoma peritonei.
    Ann Surg Oncol. 2019;26:238-243.
    PubMed     Abstract available


    December 2018
  73. MEHTSUN WT, Chipidza FE, Fernandez-Del Castillo C, Hemingway K, et al
    Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma?
    Ann Surg Oncol. 2018;25:3936-3942.
    PubMed     Abstract available


  74. REN Y, Zhang L, Xie H, She Y, et al
    Lymph Node Micrometastasis Prognosticates Survival for Patients with Stage 1 Bronchogenic Adenocarcinoma.
    Ann Surg Oncol. 2018;25:3812-3819.
    PubMed     Abstract available


    November 2018
  75. OKADA S, Shimada J, Kato D, Tsunezuka H, et al
    Long-Term Prognostic Impact of Severe Postoperative Complications After Lung Cancer Surgery.
    Ann Surg Oncol. 2018 Nov 19. pii: 10.1245/s10434-018-7061.
    PubMed     Abstract available


  76. TOYOSHIMA Y, Hara T, Matsui Y, Nagumo Y, et al
    Nodule Size After Chemotherapy and Primary-Tumor Teratoma Components Predict Malignancy of Residual Pulmonary Nodules in Metastatic Nonseminomatous Germ Cell Tumor.
    Ann Surg Oncol. 2018;25:3668-3675.
    PubMed     Abstract available


  77. SAFFARZADEH AG, Blasberg JD
    Beyond TNM: Searching for New Patient-Centric Prognostic Indicators in NSCLC.
    Ann Surg Oncol. 2018;25:3425-3426.
    PubMed    


    October 2018
  78. OKADA S, Inoue M
    ASO Author Reflections: Prognostic Nutritional Index-Based Risk Stratification for Lung Cancer.
    Ann Surg Oncol. 2018 Oct 10. pii: 10.1245/s10434-018-6884.
    PubMed    


  79. LEE SY, Park JY
    GLUT1 Variants for Predicting Prognosis After Surgery in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Oct 3. pii: 10.1245/s10434-018-6847.
    PubMed    


  80. YAMAGUCHI S, Morita M, Yamamoto M, Egashira A, et al
    Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion.
    Ann Surg Oncol. 2018;25:3280-3287.
    PubMed     Abstract available


  81. MALGRAS B, Gayat E, Aoun O, Lo Dico R, et al
    Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study.
    Ann Surg Oncol. 2018;25:3271-3279.
    PubMed     Abstract available


    September 2018
  82. TAKAMORI S, Toyokawa G
    Sarcopenia After Resection of Early Non-small Cell Lung Cancer: Is Postoperative Skeletal Muscle Loss a Risk Factor for Poor Outcomes?
    Ann Surg Oncol. 2018 Sep 22. pii: 10.1245/s10434-018-6784.
    PubMed    


  83. CLEMENT-DUCHENE C
    ASO Author Reflections: Survival Impact of N2 in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Sep 22. pii: 10.1245/s10434-018-6779.
    PubMed    


  84. LI X, Qin S, Sun X, Liu D, et al
    Prognostic Significance of Albumin-Globulin Score in Patients with Operable Non-Small-Cell Lung Cancer.
    Ann Surg Oncol. 2018 Sep 18. pii: 10.1245/s10434-018-6715.
    PubMed     Abstract available


  85. ARNDT AT
    A Little Bit of Cancer is Still Cancer: Is it Time for Lymph Node Micrometastases in Non-small Cell Lung Cancer to Get Their Due?
    Ann Surg Oncol. 2018 Sep 10. pii: 10.1245/s10434-018-6747.
    PubMed    


    August 2018
  86. LIANG RB, Yang J, Zeng TS, Long H, et al
    Incidence and Distribution of Lobe-Specific Mediastinal Lymph Node Metastasis in Non-small Cell Lung Cancer: Data from 4511 Resected Cases.
    Ann Surg Oncol. 2018 Aug 6. pii: 10.1245/s10434-018-6394.
    PubMed     Abstract available


    July 2018
  87. DO SK, Jeong JY, Lee SY, Choi JE, et al
    Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Jul 30. pii: 10.1245/s10434-018-6677.
    PubMed     Abstract available


    June 2018
  88. OKAMOTO T, Takada K, Sato S, Toyokawa G, et al
    Clinical and Genetic Implications of Mutation Burden in Squamous Cell Carcinoma of the Lung.
    Ann Surg Oncol. 2018;25:1564-1571.
    PubMed     Abstract available


    April 2018
  89. AMIT M, Tam S, Abdelmeguid AS, Kupferman ME, et al
    Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.
    Ann Surg Oncol. 2018 Apr 6. pii: 10.1245/s10434-018-6465.
    PubMed     Abstract available


    March 2018
  90. KRANTZ SB
    Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base.
    Ann Surg Oncol. 2018 Mar 26. pii: 10.1245/s10434-018-6441.
    PubMed    


    February 2018
  91. MORENO AC, Haque W, Verma V, Fang P, et al
    Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base.
    Ann Surg Oncol. 2018 Feb 26. pii: 10.1245/s10434-018-6399.
    PubMed     Abstract available


  92. OKADA S, Shimada J, Teramukai S, Kato D, et al
    Risk Stratification According to the Prognostic Nutritional Index for Predicting Postoperative Complications After Lung Cancer Surgery.
    Ann Surg Oncol. 2018 Feb 15. pii: 10.1245/s10434-018-6368.
    PubMed     Abstract available


  93. CLEMENT-DUCHENE C, Luc A, Casse JM, Vignaud JM, et al
    Survival Impact of Stations of Pathological Lymph Nodes in N2 Non-small Cell Lung Cancer in a French Hospital.
    Ann Surg Oncol. 2018 Feb 14. pii: 10.1245/s10434-018-6373.
    PubMed     Abstract available


  94. JIN K, Wang K, Zhang H, Pan Y, et al
    Solitary Pulmonary Lesion in Patients with History of Malignancy: Primary Lung Cancer or Metastatic Cancer?
    Ann Surg Oncol. 2018 Feb 7. pii: 10.1245/s10434-018-6360.
    PubMed     Abstract available


    January 2018
  95. RENAUD S, Seitlinger J, Guerrera F, Reeb J, et al
    Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma.
    Ann Surg Oncol. 2018 Jan 23. pii: 10.1245/s10434-018-6347.
    PubMed     Abstract available


  96. TAKAMORI S, Toyokawa G, Okamoto T, Shimokawa M, et al
    Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Jan 11. pii: 10.1245/s10434-017-6328.
    PubMed     Abstract available


    November 2017
  97. HENNON M, Sahia R, Yendamuri S, Demmy T, et al
    Video-Assisted Thoracic Surgery for Patients with Advanced-Stage Non-small Cell Lung Cancer: A Reply.
    Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6233.
    PubMed    


  98. FUNAI K
    Can Vessel Invasion Change the TNM Stage in Non-small Cell Lung Cancer? A Reply.
    Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6246.
    PubMed    


  99. CAO C, Yan TD, He J
    Video-Assisted Thoracic Surgery for Patients with Advanced Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2017 Nov 20. doi: 10.1245/s10434-017-6232.
    PubMed    


    August 2017
  100. SONG Z, Ye T, Ma L, Xiang J, et al
    Surgical Outcomes of Isolated Malignant Pulmonary Nodules in Patients with a History of Breast Cancer.
    Ann Surg Oncol. 2017 Aug 28. doi: 10.1245/s10434-017-6067.
    PubMed     Abstract available


  101. SEOK Y, Kang HG, Lee SY, Jeong JY, et al
    Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-6002.
    PubMed     Abstract available


    June 2016
  102. ANDTBACKA RH, Ross M, Puzanov I, Milhem M, et al
    Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial.
    Ann Surg Oncol. 2016.
    PubMed     Abstract available


  103. PATEL D, Townsend AR, Karapetis C, Beeke C, et al
    Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry.
    Ann Surg Oncol. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: